Xenocor Revenue and Competitors
Estimated Revenue & Valuation
- Xenocor's estimated annual revenue is currently $1.5M per year.
- Xenocor's estimated revenue per employee is $125,500
- Xenocor's total funding is $133.4M.
Employee Data
- Xenocor has 12 Employees.
- Xenocor grew their employee count by 9% last year.
Xenocor's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and Board Member | Reveal Email/Phone |
2 | Co-Founder/CTO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Director Engineering | Reveal Email/Phone |
5 | Senior Engineer | Reveal Email/Phone |
6 | Senior Engineer | Reveal Email/Phone |
Xenocor Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $94.6M | 377 | 28% | N/A | N/A |
#2 | $16.8M | 67 | -17% | N/A | N/A |
#3 | $485.4M | 1934 | 7% | N/A | N/A |
#4 | $43.7M | 174 | 15% | N/A | N/A |
#5 | $75M | 192 | 43% | $12.8M | N/A |
#6 | $6M | 24 | -8% | N/A | N/A |
#7 | $7.3M | 29 | -22% | N/A | N/A |
#8 | $38.4M | 153 | 3% | N/A | N/A |
#9 | $174.4M | 695 | 9% | N/A | N/A |
#10 | $6.8M | 27 | -34% | N/A | N/A |
What Is Xenocor?
XENOCOR brings to market a revolutionary technology that can extend the benefits of minimally-invasive laparoscopic surgery to hundreds of millions of people worldwide. The FDA approved Xenoscope™, is a single–use, fog-free, HD laparoscopic imaging system, which can easily replace expensive, inflexible old school technology to deliver advanced quality surgical care virtually anywhere. Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.xenocor.com. https://vimeo.com/405261371
keywords:N/A$133.4M
Total Funding
12
Number of Employees
$1.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 12 | 20% | N/A |
#2 | $35M | 12 | -8% | N/A |
#3 | $1.2M | 12 | -14% | N/A |
#4 | $1M | 12 | -37% | N/A |
#5 | $2.4M | 12 | 140% | N/A |